SG Americas Securities
AMED

SG Americas Securities’s Amedisys AMED Stock Holding History

SG Americas Securities’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-41,966
Closed -$4.13M – 3365
2025
Q2 		$4.13M Sell
41,966
-13,525
-24% -$1.28M 0.02% 520
2025
Q1 		$5.14M Sell
55,491
-763
-1% -$70.3K 0.02% 458
2024
Q4 		$5.11M Sell
56,254
-140,459
-71% -$12.9M 0.02% 343
2024
Q3 		$19M Buy
196,713
+158,398
+413% +$15.5M 0.07% 172
2024
Q2 		$3.52M Buy
38,315
+11,264
+42% +$1.05M 0.02% 706
2024
Q1 		$2.49M Sell
27,051
-36,902
-58% -$3.46M 0.01% 794
2023
Q4 		$6.08M Buy
63,953
+41,206
+181% +$3.85M 0.06% 302
2023
Q3 		$2.13M Sell
22,747
-90,806
-80% -$8.39M 0.02% 686
2023
Q2 		$10.4M Buy
113,553
+109,561
+2,745% +$8.99M 0.08% 168
2023
Q1 		$294K Sell
3,992
-3,663
-48% -$317K ﹤0.01% 2135
2022
Q4 		$639K Buy
7,655
+4,355
+132% +$393K 0.01% 1325
2022
Q3 		$319K Sell
3,300
-8,732
-73% -$1.04M ﹤0.01% 1933
2022
Q2 		$1.26M Buy
12,032
+2,040
+20% +$261K 0.01% 1100
2022
Q1 		$1.72M Buy
9,992
+2,690
+37% +$402K 0.01% 1015
2021
Q4 		$1.18M Sell
7,302
-2,380
-25% -$382K 0.01% 1514
2021
Q3 		$1.44M Buy
9,682
+1,379
+17% +$287K 0.01% 1576
2021
Q2 		$2.03M Buy
8,303
+3,055
+58% +$802K 0.01% 1112
2021
Q1 		$1.39M Sell
5,248
-9,769
-65% -$2.76M 0.01% 1305
2020
Q4 		$4.41M Buy
15,017
+11,116
+285% +$2.85M 0.02% 576
2020
Q3 		$922K Buy
3,901
+758
+24% +$172K 0.01% 1228
2020
Q2 		$624K Sell
3,143
-15,197
-83% -$2.83M 0.01% 1878
2020
Q1 		$3.37M Sell
18,340
-15,354
-46% -$2.73M 0.03% 553
2019
Q4 		$5.62M Buy
33,694
+30,705
+1,027% +$4.57M 0.05% 342
2019
Q3 		$392K Sell
2,989
-11,717
-80% -$1.53M ﹤0.01% 2015
2019
Q2 		$1.78M Buy
14,706
+11,118
+310% +$1.32M 0.01% 1092
2019
Q1 		$442K Sell
3,588
-12,546
-78% -$1.57M ﹤0.01% 1944
2018
Q4 		$1.89M Buy
16,134
+10,877
+207% +$1.28M 0.02% 913
2018
Q3 		$657K Sell
5,257
-1,972
-27% -$218K ﹤0.01% 1975
2018
Q2 		$618K Buy
7,229
+5,198
+256% +$382K 0.01% 1840
2018
Q1 		$123K Buy
+2,031
New +$116K ﹤0.01% 2779
2017
Q4 		– Sell
-4,219
Closed -$236K – 3163
2017
Q3 		$236K Buy
4,219
+476
+13% +$25.2K ﹤0.01% 2449
2017
Q2 		$235K Buy
3,743
+1,226
+49% +$71.4K ﹤0.01% 2307
2017
Q1 		$129K Sell
2,517
-66
-3% -$3.15K ﹤0.01% 2793
2016
Q4 		$110K Sell
2,583
-4,571
-64% -$194K ﹤0.01% 2800
2016
Q3 		$339K Buy
+7,154
New +$357K ﹤0.01% 2063
2015
Q1 		– Sell
-7,380
Closed -$217K – 2497
2014
Q4 		$217K Sell
7,380
-345
-4% -$8.52K ﹤0.01% 2359
2014
Q3 		$156K Buy
+7,725
New +$149K ﹤0.01% 2123
2014
Q1 		– Sell
-29,146
Closed -$426K – 2406
2013
Q4 		$426K Buy
29,146
+8,078
+38% +$130K ﹤0.01% 1647
2013
Q3 		$363K Buy
+21,068
New +$313K ﹤0.01% 1798

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SG Americas Securities's AMED Position: Q3 2025 in Review

SG Americas Securities sold out of Amedisys (AMED) in Q3 2025, closing a stake of 41,966 shares — an estimated $4.13M sold.

SG Americas Securities first reported a position in AMED in Q3 2013 and held it in 39 quarters. The position peaked at $19M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • SG Americas Securities reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 41,966 Amedisys shares in Q3 2025, an estimated $4.13M.
  • SG Americas Securities first reported a position in Amedisys in Q3 2013 and held it in 39 quarters.
  • SG Americas Securities's Amedisys position peaked at $19M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.